Trials / Completed
CompletedNCT01410266
Reducing the Need for In-Clinic Follow-Up for Medical Abortion in Moldova and Uzbekistan
The Acceptability and Feasibility of Reducing the Need for In-Clinic Follow-Up for First Trimester Medical Abortion in Moldova and Uzbekistan
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 2,400 (actual)
- Sponsor
- Gynuity Health Projects · Academic / Other
- Sex
- Female
- Age
- 16 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether an alternative method of follow-up after medical abortion is acceptable and feasible for use in Moldova and Uzbekistan.
Detailed description
Medical abortion using mifepristone and misoprostol is a highly effective procedure, but access to it may be impeded by the fact that not all women can afford or want to return for a follow-up visit. This often results in a high loss to follow-up rate. Additionally, with medical abortions of those women who do return for follow-up, higher costs are borne by both the woman and the healthcare system. This study compares two methods of follow-up after medical abortion: standard of care versus alternative follow-up. The former involves a routine clinic visit two weeks after misoprostol administration. The latter consists of a low-sensitivity pregnancy test and a self-administered questionnaire. Based on the results of the test and questionnaire, women may be flagged as needing in-clinic follow-up or discharged from the study if their abortion is complete.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Alternative follow-up | Alternative follow-up consists of a self-administered semi-quantitative pregnancy test designed to measure urine beta-hCG levels, and a self-administered questionnaire consisting of 7 questions. Results of both are reviewed by the provider to determine if in-clinic follow-up is needed. |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2011-08-05
- Last updated
- 2012-12-03
Locations
7 sites across 2 countries: Moldova, Uzbekistan
Source: ClinicalTrials.gov record NCT01410266. Inclusion in this directory is not an endorsement.